Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 60 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT07098364
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +20 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT05052528
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
NCT06649812
- Conditions
- Hemic and Lymphatic Diseases, High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements, Immune System Diseases, +23 more
- Locations
-
- Banner University Medical Center - Tucson Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
- Cedars-Sinai Medical Center Los Angeles, California, United States
- Smilow Cancer Hospital-Derby Care Center Derby, Connecticut, United States
NCT05672251
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +20 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Recruiting
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
NCT05077527
- Conditions
- AIDS-Related Diffuse Large B-cell Lymphoma, AIDS-Related Non-Hodgkin Lymphoma, Blood-Borne Infections, +36 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- University of Illinois at Chicago Chicago, Illinois, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- Montefiore Medical Center - Moses Campus The Bronx, New York, United States
NCT06854159
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +12 more
- Locations
-
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
NCT06905509
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +23 more
- Locations
-
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
NCT06536049
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +22 more
- Locations
-
- University of Minnesota/Masonic Cancer Center Minneapolis, Minnesota, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Recruiting
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
NCT05272384
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +15 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- Yale University New Haven, Connecticut, United States
NCT06784726
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +20 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT06859008
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Disease Attributes, +39 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT03418038
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +27 more
- Locations
-
- Mayo Clinic Health Systems-Mankato Mankato, Minnesota, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
- Mayo Clinic Health System-Eau Claire Clinic Eau Claire, Wisconsin, United States
- Mayo Clinic Health System-Franciscan Healthcare La Crosse, Wisconsin, United States
NCT07042438
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +14 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT05432635
- Conditions
- B-Cell Non-Hodgkin Lymphoma, Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, +17 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Conditions
- B-Cell Non-Hodgkin Lymphoma, Chronic Disease, Disease Attributes, +35 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
NCT05800405
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT05633615
- Conditions
- Diffuse Large B-cell Lymphoma, Grade 3b Follicular Lymphoma, Hemic and Lymphatic Diseases, +15 more
- Locations
-
- Banner University Medical Center - Tucson Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
- Highlands Oncology Group - Fayetteville Fayetteville, Arkansas, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
NCT05890352
- Conditions
- Grade 3b Follicular Lymphoma, Hemic and Lymphatic Diseases, High Grade B-Cell Lymphoma, +14 more
- Locations
-
- Banner University Medical Center - Tucson Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
- Tower Cancer Research Foundation Beverly Hills, California, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
Recruiting
Phase I Clinical Trial of RC19D2 Cell Injection in the Treatment of Diffuse Large B-cell Lymphoma
NCT06047197
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- Hematology Hospital of the Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
Not Yet Recruiting
Lymphodepletion With Low Dose Total Body Irradiation Before Standard of Care Tisagenlecleucel for the Treatment of Relapsed and Recurrent Large B-cell Lymphoma
NCT07676877
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States